Investigational Drug Information for Dapansutrile
✉ Email this page to a colleague
What is the development status for investigational drug Dapansutrile?
Dapansutrile is an investigational drug.
There have been 7 clinical trials for Dapansutrile.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2022.
The most common disease conditions in clinical trials are Syndrome, Arthritis, Gouty, and Schnitzler Syndrome. The leading clinical trial sponsors are Olatec Therapeutics LLC, University of Virginia, and European Union (Horizon Europe Programme).
Summary for Dapansutrile
| US Patents | 0 |
| International Patents | 26 |
| US Patent Applications | 41 |
| WIPO Patent Applications | 22 |
| Japanese Patent Applications | 7 |
| Clinical Trial Progress | Phase 1 (2022-12-01) |
| Vendors | 38 |
Recent Clinical Trials for Dapansutrile
| Title | Sponsor | Phase |
|---|---|---|
| Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia | European Union (Horizon Europe Programme) | Phase 2 |
| Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia | Olatec Therapeutics LLC | Phase 2 |
| Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia | State Secretariat for Education Research and Innovation, Switzerland | Phase 2 |
Clinical Trial Summary for Dapansutrile
Top disease conditions for Dapansutrile
Top clinical trial sponsors for Dapansutrile
US Patents for Dapansutrile
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Dapansutrile
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Dapansutrile | Australia | AU2011344030 | 2030-12-15 | ⤷ Sign Up |
| Dapansutrile | Brazil | BR112013014583 | 2030-12-15 | ⤷ Sign Up |
| Dapansutrile | Canada | CA2820625 | 2030-12-15 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
